Search

  • HOME
  • Search
Original Articles
Lung Cancer
Predictive Factors for Switched EGFR-TKI Retreatment in Patients with EGFR-Mutant Non-Small Cell Lung Cancer
Byoung Soo Kwon, Ji Hyun Park, Woo Sung Kim, Joon Seon Song, Chang-Min Choi, Jin Kyung Rho, Jae Cheol Lee
Tuberc Respir Dis. 2017;80(2):187-193.   Published online March 31, 2017
Full textFull text    PubreaderPubReader    PDFPDF    
Case Reports
Second Complete Remission of Relapsed Stage IV Non-Small Cell Lung Cancer Following Retreatment
Su Jin Yoo, Jeong Eun Lee, Sun Young Jung, Dong Il Park, Myoung Rin Park, Hee Sun Park, Sung Soo Jung, Ju Ock Kim, Sun Young Kim
Tuberc Respir Dis. 2012;72(4):381-385.   Published online April 30, 2012
Full textFull text    PubreaderPubReader    PDFPDF    
Original Articles
A Comparative Study of Effect of Secondary Anti-tuberculosis Drugs in the Retreatment of Pulmonary Tuberculosis.
Hyun Cheol Ha, Eun Soo Kwon, In Hwan Chio, Su Hee Hwang, Seung Kyu Park, Sun Dae Song
Tuberc Respir Dis. 1998;45(6):1154-1166.   Published online December 1, 1998
PDFPDF    
The Adjunctive Role of Resectional Surgery for the Treatment of Multidrug-Resistant Pulmonary Tuberculosis.
Won Jung Koh, Jae Ho Lee, Chul Gyu Yoo, Young Whan Kim, Hee Soon Chung, Sook Whan Sung, Jung Gi Im, Joo Hyun Kim, Young Soo Shim, Sung Koo Han
Tuberc Respir Dis. 1997;44(5):975-991.   Published online October 1, 1997
PDFPDF    
Comparative Study on the Regimens with Pyrazinamide orOfloxacin in the retreatment of pulmonary tuberculosis.
In Hwan Chol, Seung Kyu Park, Kyeong Ho Kim, Jin Ho Kim, Cheon Tae Kim, Sun Dae Song
Tuberc Respir Dis. 1996;43(6):871-881.   Published online December 1, 1996
PDFPDF    
Clinical Effects of Prothinoamide, Cycloserine, Para-Aminosalicylic Acid, Ofloxasine in Retreatment of Pulmonary Tuberculosis.
Jae Rak Hong, Min Kyu Yoo, Jae Man Jeong, Young Jun Kim, Mal Hyeon Son
Tuberc Respir Dis. 1996;43(5):693-700.   Published online October 1, 1996
PDFPDF    
A Clinical Effect of Ofloxacin, Prothionamide, Cycloserine Streptomycin (Kanamycin or Tuberactinomycin) in Retreatment of Pulmonary Tuberculosis.
Ju Young Song, Min Kyu Yoo, Jae Rack Hong, Jae Man Jeong, Young Jun Kim, Moon Shik Kim
Tuberc Respir Dis. 1995;42(3):295-301.   Published online June 1, 1995
PDFPDF    
Clinical and Bacteriologic Characteristics of Retreated Tuberculosis Patients.
Seoung Joon Oh, Ki Heon Yoon, Jee Hong Yoo, Hong Mo Kang
Tuberc Respir Dis. 1995;42(1):19-24.   Published online February 1, 1995
PDFPDF    
The clinical aspects of pulmonary tuberculosis patient failed in retreatment.
Young Jae Im, Ju Young Song, Jae Man Jeong, Young Jun Kim, Moon Shik Kim
Tuberc Respir Dis. 1993;40(4):404-409.   Published online August 1, 1993
PDFPDF    
A clinical effect of retreatment by prothionamide, cycloserine, para-aminosalicylic acid, streptomycin(kanamycin or tuberactinomyc-in) on pulmonary tuberculosis.
Cheol Shick Shin, Young Jae Im, Young Jun Kim, Seok Shin Koh, Moon Shik Kim
Tuberc Respir Dis. 1992;39(2):167-171.   Published online April 1, 1992
PDFPDF    

Tuberculosis and
Respiratory Diseases

Print ISSN: 1738-3536
Online ISSN: 2005-6184



ABOUT
ARTICLE & TOPICS
Article category

Browse all articles >

Topics

Browse all articles >

BROWSE ARTICLES
FOR CONTRIBUTORS
Editorial Office
101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347    Fax: +82-2-572-6683    E-mail: katrdsubmit@lungkorea.org                

Copyright © 2024 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Developed in M2PI

Close layer
prev next